坏死性凋亡在血液系统恶性疾病中的研究进展  

Research Progress of Necroptosis in Hematological Malignant Diseases

作　　者：王亚楠[1] 郝建萍[1] 

机构地区：[1]新疆医科大学第一附属医院血液病中心,新疆 乌鲁木齐

出　　处：《临床医学进展》2024年第2期2837-2842,共6页Advances in Clinical Medicine

摘　　要：坏死性凋亡是一种主要通过细胞内的信号传导途径调控的细胞死亡方式,在血液系统恶性疾病的发生和发展过程中发挥着重要作用。本文通过分析坏死性凋亡在血液系统恶性疾病中的潜在应用前景,探讨坏死性凋亡的调控机制和干预方法,有望为血液系统恶性疾病的治疗提供新的思路和策略。Necroptosis is a mode of cell death mainly regulated by intracellular signal transduction pathways, which plays an important role in the occurrence and development of hematological malignant dis-eases. By analyzing the potential application prospect of necroptosis in hematological malignant diseases, discussing the regulation mechanism and intervention methods of necroptosis, it is ex-pected to provide new ideas and strategies for the treatment of hematological malignant diseases.

关 键 词：坏死性凋亡 血液系统恶性疾病 治疗 

分 类 号：R73[医药卫生—肿瘤]